Previous Hold Today APVO ranks #2539 as HOLD CANDIDATE. Next Hold
Today APVO ranks #2539 as HOLD CANDIDATE.

APVO stock Aptevo Therapeutics Inc

APVO stock
Aptevo Therapeutics Inc

18 January 2019
Change 2.55%
Chart period: 2018-10-19 - 2019-01-18




Request Prediction

Aptevo Therapeutics Inc Stock Analysis

Technical stock analysis for 18 January 2019

Hold candidate since 2019-01-18
Shorts n/a
Cash n/a
Loans n/a
Beta 3.26
ROA -46.98

Aptevo Therapeutics Inc gained 2.55% in the last trading day, rising from $1.57 to $1.61 The price has been going up and down for this period, and there has been a 6.62% gain for the last 2 weeks. Volume fell in the last day by -137 646 shares, and in total, 69 910 shares bought and sold for approximately $112 555.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Friday, 18th Jan 2019) of the APVO stock was $1.61. This is 2.55% more than the trading day before Thursday, 17th Jan 2019.

During day the stock fluctuated 3.84% from a day low at $1.56 to a day high of $1.62.

30 day high of the APVO stock price was $1.71 and low was $1.11.
90 day high was $4.00 and low was $1.11.
52 week high for the Aptevo Therapeutics Inc - $6.35 and low - $1.11.


Aptevo Therapeutics Inc has broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction there will be support on the roof on the current trend broken, which is $1.52, a level that may pose a second chance to hit a runner. According to fan-theory $2.54 will be the next possible trendtop level and thereby pose a resistance level which may not be broken on the first attempt.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Thursday January 17, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Aptevo Therapeutics Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.74. On a fall, the stock will find some support from the short-term average at $1.60. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 73 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Aptevo Therapeutics Inc finds support from accumulated volume at $1.57.

Support: $1.57 Price: $1.61 Resistance: $1.64


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.06 between high and low, or 3.84%. For the last week the stock has had a daily average volatility of 5.47%.

The stock is extremely overbought on RSI14 (73). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stoploss: $1.53 (-5.21%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 73 and this increases the risk substantially. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High


Aptevo Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Hold/Accumulate.

Previous Hold Today APVO ranks #2539 as HOLD CANDIDATE. Next Hold
Today APVO ranks #2539 as HOLD CANDIDATE.